Asia Pacific Cerebrospinal Fluid Management Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis – by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)


No. of Pages: 82    |    Report Code: TIPRE00028018    |    Category: Life Sciences

Asia Pacific Cerebrospinal Fluid Management Market
Buy Now

The Asia Pacific cerebrospinal fluid management market was valued at US$ 389.53 million in 2022 and is expected to reach US$ 613.54 million by 2030; it is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

Increasing Focus on CSF Management in Neurological Disease Treatments Fuels the Asia Pacific Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson’s Disease (PD), Alzheimer’s Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer’s disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer’s disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

Asia Pacific Cerebrospinal Fluid Management Market Overview

The Asia Pacific cerebrospinal fluid management is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is the fastest-growing market for cerebrospinal fluid management in global scenario. The cerebrospinal fluid management market growth in this region is attributed to growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.

Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

Asia Pacific Cerebrospinal Fluid Management Market Segmentation

The Asia Pacific cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the Asia Pacific cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the Asia Pacific cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific cerebrospinal fluid management market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific cerebrospinal fluid management market share in 2022.

B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, Natus Medical Inc, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the Asia Pacific cerebrospinal fluid management market.

The List of Companies - Asia Pacific Cerebrospinal Fluid Management Market

  1. B. Braun SE
  2. Integra LifeSciences Holdings Corp
  3. Medtronic Plc
  4. Natus Medical Inc
  5. Spiegelberg GmbH & Co KG

 

Frequently Asked Questions
How big is the Asia Pacific Cerebrospinal Fluid Management Market?

The Asia Pacific Cerebrospinal Fluid Management Market is valued at US$ 389.53 Million in 2022, it is projected to reach US$ 613.54 Million by 2030.

What is the CAGR for Asia Pacific Cerebrospinal Fluid Management Market by (2022 - 2030)?

As per our report Asia Pacific Cerebrospinal Fluid Management Market, the market size is valued at US$ 389.53 Million in 2022, projecting it to reach US$ 613.54 Million by 2030. This translates to a CAGR of approximately 5.8% during the forecast period.

What segments are covered in this report?

The Asia Pacific Cerebrospinal Fluid Management Market report typically cover these key segments-

  • Product (CSF Shunts and CSF Drainage Systems)
  • End User (Hospitals, Clinics, Ambulatory Surgical Centers)

What is the historic period, base year, and forecast period taken for Asia Pacific Cerebrospinal Fluid Management Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Cerebrospinal Fluid Management Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Asia Pacific Cerebrospinal Fluid Management Market?

    The Asia Pacific Cerebrospinal Fluid Management Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • B. Braun SE
  • Integra LifeSciences Holdings Corp
  • Medtronic Plc
  • Natus Medical Inc
  • Spiegelberg GmbH & Co KG
  • Who should buy this report?

    The Asia Pacific Cerebrospinal Fluid Management Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Cerebrospinal Fluid Management Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now